Cellular Origins

Cellular Origins is a biotechnology company founded in 2023, focused on scalable automation solutions for cell therapy manufacturing. Headquartered in Melbourn, United Kingdom, the company aims to enhance the production of cell and gene therapies (CGTs) through industrialization, digitalization, and flexible automation. It partners with industry leaders to streamline processes, reduce costs, and improve patient access to treatments. The company's primary offering is Constellation®, a mobile robotic ecosystem that automates cell therapy processes. This platform features modularity and configurability to meet specific therapy needs, significantly increases manufacturing space utilization, and reduces labor requirements and costs. Constellation® ensures high output and quality in CGT production, supporting therapeutic developers with secure and repeatable manufacturing solutions. Cellular Origins also collaborates with key partners, including Thermo Fisher Scientific, to optimize robotic CGT production.